Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Single-arm, Phase I Clinical Trial to Evaluate the Safety and Efficacy of TX103 CAR-T Cells in Participants With Advanced Solid Tumors

NCT07231081 is registered in ClinicalTrials.gov with Tcelltech Inc. as lead sponsor.

NCT NCT07231081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07231081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Single-arm, Phase I Clinical Trial to Evaluate the Safety and Efficacy of TX103 CAR-T Cells in Participants With Advanced Solid Tumors
Lead sponsor
Tcelltech Inc.
Phase
Phase 1
Overall status
Suspended
Start date
October 16, 2025
Completion date
December 20, 2027
Enrollment
85 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors